Everest Organics

260.00
+8.45
(3.36%)
Market Cap
252.51 Cr
EPS
0.17
PE Ratio
59.93
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
307.15
52 Week low
110.00
PB Ratio
5.79
Debt to Equity
1.18
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,683.45 4,03,916.05 34.10 49,887.20 12.06 9,648 13.77 52.67
5,620.45 1,49,205.29 72.77 8,184.00 0.89 1,600 64.53 45.57
1,461.90 1,18,065.10 23.53 26,520.70 14.17 4,155 47.38 52.92
3,056.05 1,03,430.62 56.27 10,785.70 11.59 1,656 13.54 47.23
1,107.95 92,448.55 17.17 28,905.40 12.36 5,578 1.69 30.37
2,201.15 90,812.16 43.84 10,615.60 19.57 1,942 -16.38 35.15
1,968.45 89,800.21 31.28 20,141.50 19.94 1,936 38.82 43.62
883.10 88,860.52 19.73 19,831.50 13.82 3,831 29.92 40.81
1,094.75 63,583.26 18.24 29,559.20 17.55 3,169 -10.04 43.94
29,597.00 62,891.56 47.49 6,097.20 10.80 1,201 16.01 49.75
Growth Rate
Revenue Growth
4.26 %
Net Income Growth
-150.00 %
Cash Flow Change
-10.86 %
ROE
-176.92 %
ROCE
72.40 %
EBITDA Margin (Avg.)
44.69 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
107
100
108
113
156
169
183
202
190
198
172
Expenses
98
94
101
105
138
148
159
194
182
186
164
EBITDA
8
6
7
8
18
21
24
9
8
12
8
Operating Profit %
7 %
6 %
6 %
6 %
11 %
12 %
13 %
3 %
1 %
6 %
3 %
Depreciation
3
3
2
3
3
3
3
4
5
6
6
Interest
3
3
3
3
3
3
3
3
3
6
5
Profit Before Tax
2
0
2
2
12
14
17
2
0
1
-4
Tax
0
0
0
1
5
3
4
1
0
1
0
Net Profit
2
0
1
2
8
11
14
1
-0
0
-4
EPS in ₹
1.78
0.54
1.69
2.14
9.39
13.62
17.14
1.43
-0.23
0.17
-5.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
67
76
86
94
107
120
135
178
202
227
Fixed Assets
24
27
33
34
39
39
44
49
55
52
Current Assets
42
47
49
58
67
79
89
118
133
150
Capital Work in Progress
0
1
1
1
0
1
0
8
12
21
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
43
47
52
60
69
80
92
121
136
153
Total Liabilities
67
76
86
94
107
120
135
178
202
227
Current Liabilities
50
56
63
67
71
74
77
113
138
160
Non Current Liabilities
11
14
7
8
10
12
11
19
18
21
Total Equity
6
6
16
19
26
34
47
47
46
46
Reserve & Surplus
-4
3
8
11
18
26
39
39
38
38
Share Capital
9
3
8
8
8
8
8
8
8
8

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
-0
1
0
-0
-1
0
0
Investing Activities
-3
-7
-8
-4
-5
-6
-12
-17
-16
-13
Operating Activities
4
7
10
5
9
10
14
14
18
16
Financing Activities
-2
-0
-2
-1
-3
-3
-2
2
-3
-3

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.06 %
0.06 %
0.05 %
0.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.04 %
18.48 %
18.27 %
18.84 %
18.91 %
19.27 %
19.29 %
19.38 %
19.40 %
19.41 %
19.60 %
19.99 %
20.00 %
20.05 %
20.13 %
18.63 %
Others
6.78 %
7.34 %
7.56 %
6.99 %
6.91 %
6.55 %
6.53 %
6.44 %
6.42 %
6.41 %
6.22 %
5.83 %
5.79 %
5.75 %
5.67 %
7.17 %
No of Share Holders
8,122
11,174
10,784
11,135
11,154
11,244
11,250
11,100
10,834
10,634
10,494
10,242
10,023
9,792
9,996
9,326

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Receipt Of Listing Approval From BSE Limited
2 days ago
Intimation Of Korea Drug Master File (KDMF) Approval For CompanyS Rabeprazole Sodium API
Feb 18, 2025, 14:54
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 13, 2025, 11:27
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Feb 13, 2025, 11:06
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Feb 13, 2025, 11:05
Integrated Filing (Financial)
Feb 11, 2025, 18:27
Board Meeting Outcome for Outcome Of The Board Meeting Held Today
Feb 11, 2025, 18:20
Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024.
Feb 11, 2025, 18:18
Board Meeting Intimation for Board Meeting Scheduled To Be Held On Tuesday February 11 2025.
Feb 05, 2025, 11:59
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 22, 2025, 09:49
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Jan 15, 2025, 17:33
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Jan 15, 2025, 14:04
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Jan 15, 2025, 09:58
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 14, 2025, 13:03
Certificate From Statutory Auditor In Terms Of Regulation 169(4) & (5) Of The SEBI (ICDR) Regulations 2018
Jan 13, 2025, 21:59
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Jan 13, 2025, 15:11
Announcement under Regulation 30 (LODR)-Change in Management
Jan 13, 2025, 14:32
Announcement under Regulation 30 (LODR)-Change in Management
Jan 13, 2025, 13:53
Announcement under Regulation 30 (LODR)-Allotment
Jan 13, 2025, 13:13
Board Meeting Outcome for Outcome Of Board Meeting Dated 13.01.2025
Jan 13, 2025, 13:11
Board Meeting Intimation for Allotment
Jan 08, 2025, 21:15
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Jan 08, 2025, 20:01
Shareholder Meeting / Postal Ballot-Outcome of EGM
Jan 08, 2025, 18:15
Closure of Trading Window
Dec 27, 2024, 14:32
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dec 18, 2024, 14:38
Notice Of EGM Scheduled To Be Held On Wednesday, January 08, 2025
Dec 17, 2024, 16:45
Additional Information Required Under SEBI Circular No. SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated July 13, 2023 Read With Regulation 30 Of SEBI(LODR) Regulations, 2015 In Continuation To The Outcome Of Board Meeting Submitted On December 12, 2024
Dec 16, 2024, 16:02
Announcement under Regulation 30 (LODR)-Preferential Issue
Dec 13, 2024, 22:21
Corrigendum To The Outcome Of Board Meeting Held On December 12, 2024
Dec 13, 2024, 22:17
Board Meeting Outcome for 1. Increase Of Authorised Share Capital2. Issue Of Equity Shares On Preferential Basis
Dec 12, 2024, 21:36
Board Meeting Intimation for For Fund Raising Through Preferential Issue
Dec 09, 2024, 17:32
Cancellation of Board Meeting
Dec 09, 2024, 14:57
Board Meeting Intimation for Prior Intimation Of Board Meeting Going To Be Held On 10Th December, 2024 To Consider Preferential Issue.
Dec 07, 2024, 13:32
Announcement under Regulation 30 (LODR)-Resignation of Director
Dec 07, 2024, 10:53
Announcement under Regulation 30 (LODR)-Resignation of Director
Dec 04, 2024, 15:46
Announcement under Regulation 30 (LODR)-Resignation of Director
Dec 04, 2024, 14:23
Announcement under Regulation 30 (LODR)-Resignation of Director
Dec 04, 2024, 13:43
Newspaper Publication Of Quarterly Financial Result
Nov 14, 2024, 14:31
Appointment Of Company Secretary
Nov 13, 2024, 19:33
Appointment Of Director
Nov 13, 2024, 19:29
Board Meeting Outcome for Outcomes Of The Meeting
Nov 13, 2024, 15:43
Financial Result For Quarter Ended 30-09-2024
Nov 13, 2024, 15:03
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Quarter Ended September 30, 2024
Nov 08, 2024, 17:45
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 15, 2024, 13:26
Announcement under Regulation 30 (LODR)-Retirement
Oct 04, 2024, 16:10
Closure of Trading Window
Sep 30, 2024, 16:13
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 28, 2024, 19:13
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 27, 2024, 17:13
Announcement under Regulation 30 (LODR)-Demise
Sep 09, 2024, 17:28
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 07, 2024, 13:25

Technical Indicators

RSI(14)
Neutral
57.20
ATR(14)
Less Volatile
13.55
STOCH(9,6)
Neutral
70.22
STOCH RSI(14)
Overbought
98.82
MACD(12,26)
Bullish
2.81
ADX(14)
Weak Trend
16.80
UO(9)
Bearish
53.18
ROC(12)
Uptrend And Accelerating
4.50
WillR(14)
Overbought
-3.92